The scope maker expects to report $18.6 million in total revenue for the fourth quarter, up from $18.3 million in the fourth quarter of 2014. Revenue for the full year is predicted to be $72.3 million, up 18 percent from $61.4 million in 2014.
The company’s fourth quarter revenue consisted of:
• Imaging: $5.2 million
• Single-use products: $9.5 million
• Pathology: $3.9 million
EndoChoice shipped 25 of its Fuse Endoscopy systems during the fourth quarter of 2015, and a total of 99 were shipped for the full year. The company will report its full fourth quarter and full year financial results March 3.
More articles on gastroenterology:
Dr. Lawrence Kosinski’s SonarMD partners with Digestive Health Center of New Jersey
FDA clears 51 GI/endoscopy devices in 2015
Exact Sciences expects to double number of Cologuard tests completed in 2016
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.